It’s time to start a specific thread on whether the COVID-19 application will proceed.
I think there is enough evidence to suggest the COVID-19 application will not be a goer. The Novartis delay is quite inexplicable given the global emergency.
Sure, there might be some reason for Novartis not proceeding quickly. But absence any clarifying statement it is not clear what that could be. The mystery deepens because of the confidant statement three months or so ago that the announcement would be in a few weeks.
If Novartis walk away, what will that mean for the Covid-19 application?
Growing doubt on COVID-19 Application
-
- There are more pages in this discussion • 4,734 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |